First Time Loading...

Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 212.9 USD -0.88% Market Closed
Updated: Jun 10, 2024

Charles River Laboratories International Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Charles River Laboratories International Inc
Accrued Liabilities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Charles River Laboratories International Inc
NYSE:CRL
Accrued Liabilities
$380.5m
CAGR 3-Years
-1%
CAGR 5-Years
13%
CAGR 10-Years
13%
Thermo Fisher Scientific Inc
NYSE:TMO
Accrued Liabilities
$4.3B
CAGR 3-Years
8%
CAGR 5-Years
15%
CAGR 10-Years
10%
Danaher Corp
NYSE:DHR
Accrued Liabilities
$2.6B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Accrued Liabilities
$319.5m
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accrued Liabilities
$544m
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
-3%
IQVIA Holdings Inc
NYSE:IQV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Charles River Laboratories International Inc's Accrued Liabilities?
Accrued Liabilities
380.5m USD

Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Accrued Liabilities amounts to 380.5m USD.

What is Charles River Laboratories International Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
13%

Over the last year, the Accrued Liabilities growth was -4%. The average annual Accrued Liabilities growth rates for Charles River Laboratories International Inc have been -1% over the past three years , 13% over the past five years , and 13% over the past ten years .